Walgreens (NYSE: WAG) (Nasdaq: WAG) had July sales of $6.03 billion, an increase of 8.0 percent from $5.59 billion for the same month in fiscal 2012.
Total front-end sales increased 3.6 percent compared with the same month in fiscal 2012, while comparable store front-end sales increased 2.3 percent. Customer traffic in comparable stores decreased 1.2 percent while basket size increased 3.5 percent.
Prescriptions filled at comparable stores increased by 9.5 percent in July and increased 7.3 percent on a calendar day-shift adjusted basis. This year’s July had one additional Wednesday and one fewer Sunday compared with July 2012. These calendar shifts positively impacted prescriptions filled at comparable stores by 2.2 percentage points.
The company said the percentage of Express Scripts prescriptions returning to its pharmacies continued to increase in July.July pharmacy sales increased by 9.9 percent, while comparable store pharmacy sales increased 8.8 percent and increased by a calendar day-shift adjusted 6.6 percent. Calendar day shifts positively impacted pharmacy sales in comparable stores by 2.2 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 2.8 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 64.6 percent of total sales for the month. Sales in comparable stores increased by 6.3 percent in July. Calendar day shifts positively impacted total comparable sales by 1.4 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 1.8 percentage points. Registrations for Walgreens Balance ® Rewards loyalty program, which launched in September 2012, totaled 79 million through July. Calendar 2013 sales to date were $42.02 billion, an increase of 3.4 percent from $40.64 billion in 2012. Fiscal 2013 year-to-date sales for the first 11 months were $66.05 billion, up 0.4 percent from $65.79 billion in the comparable period in fiscal 2012.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV